1. Empirical Investigation of the Ethical Reasoning of Physicians and Molecular Biologists—the Importance of the Four Principles of Biomedical Ethics;Ebbesen;Philosophy, Ethics, and Humanities in Medicine,2007
2. 3. Diaz, J.I. , “How Will COVID-19 Impact Biosimilar Trends In The Top 5 European Markets?” Biosimilar Development (May 5, 2020), available at (last visited August 17, 2020).
3. 17. C. Gastieger, A.S.K. Jones, M. Kleinstäuber, et al., “The Effects of Message Framing on Patients’ Perceptions and Willingness to Change to a Biosimilar in a Hypothetical Drug Switch,” Arthritis Care Research (2019), doi: 10.1002/acr.24012.
4. 11. Charles Gard and others v. UK, App n° 39793/17 (2017), at the core of this case, the interpretation of the “best interest of the child”. Prior decisions of the Court: see Hristozov and others v. Bulgaria, App. Nos. 47039/11 and 358/12 (2012) and Durisotto v. Italy, App. n° 62804/13 (2014). The applications were found inadmissible.
5. 15. IQVIA, D. Long, Vice President, Industry Relations, “Global /US Generics and Biosimilars: Trends, Issues and Outlook,” (February 5, 2019), available at (last visited August 17, 2020)